159 related articles for article (PubMed ID: 15190963)
1. Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia.
Derhaschnig U; Bergmair D; Marsik C; Schlifke I; Wijdenes J; Jilma B
Crit Care Med; 2004 May; 32(5):1136-40. PubMed ID: 15190963
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.
Levi M; ten Cate H; Bauer KA; van der Poll T; Edgington TS; Büller HR; van Deventer SJ; Hack CE; ten Cate JW; Rosenberg RD
J Clin Invest; 1994 Jan; 93(1):114-20. PubMed ID: 8282778
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.
de Jonge E; Dekkers PE; Creasey AA; Hack CE; Paulson SK; Karim A; Kesecioglu J; Levi M; van Deventer SJ; van Der Poll T
Blood; 2000 Feb; 95(4):1124-9. PubMed ID: 10666180
[TBL] [Abstract][Full Text] [Related]
4. Effects of the pan-selectin antagonist bimosiamose (TBC1269) in experimental human endotoxemia.
Mayr FB; Firbas C; Leitner JM; Spiel AO; Reiter RA; Beyer D; Meyer M; Wolff G; Jilma B
Shock; 2008 Apr; 29(4):475-82. PubMed ID: 18598003
[TBL] [Abstract][Full Text] [Related]
5. Defibrotide enhances fibrinolysis in human endotoxemia - a randomized, double blind, crossover trial in healthy volunteers.
Schoergenhofer C; Buchtele N; Gelbenegger G; Derhaschnig U; Firbas C; Kovacevic KD; Schwameis M; Wohlfarth P; Rabitsch W; Jilma B
Sci Rep; 2019 Jul; 9(1):11136. PubMed ID: 31366975
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia.
Leitner JM; Firbas C; Mayr FB; Reiter RA; Steinlechner B; Jilma B
Clin Pharmacol Ther; 2006 Jan; 79(1):23-34. PubMed ID: 16413239
[TBL] [Abstract][Full Text] [Related]
7. The C-reactive protein (+)1444C/T alteration modulates the inflammation and coagulation response in human endotoxemia.
Marsik C; Sunder-Plassmann R; Jilma B; Kovar FM; Mannhalter C; Wagner O; Rumpold H; Endler G
Clin Chem; 2006 Oct; 52(10):1952-7. PubMed ID: 16916988
[TBL] [Abstract][Full Text] [Related]
8. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC.
Taylor FB; Wada H; Kinasewitz G
Crit Care Med; 2000 Sep; 28(9 Suppl):S12-9. PubMed ID: 11007191
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans.
Jilma B; Marsik C; Mayr F; Graninger MT; Taylor FB; Ribel MC; Erhardtsen E; Handler S; Eichler HG
Clin Pharmacol Ther; 2002 Oct; 72(4):403-10. PubMed ID: 12386642
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzees.
Levi M; van Der POLL T; ten CATE H; Kuipers B; Biemond BJ; Jansen HM; ten CATE JW
Am J Respir Crit Care Med; 1998 Jul; 158(1):92-8. PubMed ID: 9655712
[TBL] [Abstract][Full Text] [Related]
11. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.
van der Poll T; Levi M; Hack CE; ten Cate H; van Deventer SJ; Eerenberg AJ; de Groot ER; Jansen J; Gallati H; Büller HR
J Exp Med; 1994 Apr; 179(4):1253-9. PubMed ID: 8145042
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia.
Pajkrt D; van der Poll T; Levi M; Cutler DL; Affrime MB; van den Ende A; ten Cate JW; van Deventer SJ
Blood; 1997 Apr; 89(8):2701-5. PubMed ID: 9108387
[TBL] [Abstract][Full Text] [Related]
13. Lepirudin blunts endotoxin-induced coagulation activation.
Pernerstorfer T; Hollenstein U; Hansen JB; Stohlawetz P; Eichler HG; Handler S; Speiser W; Jilma B
Blood; 2000 Mar; 95(5):1729-34. PubMed ID: 10688831
[TBL] [Abstract][Full Text] [Related]
14. The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia.
Spiel AO; Firbas C; Mayr FB; Leitner JM; Schmidt B; Knöbl P; Varadi K; Jilma B
Thromb Haemost; 2005 Dec; 94(6):1148-55. PubMed ID: 16411386
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Protease-Activated Receptor (PAR1) Reduces Activation of the Endothelium, Coagulation, Fibrinolysis and Inflammation during Human Endotoxemia.
Schoergenhofer C; Schwameis M; Gelbenegger G; Buchtele N; Thaler B; Mussbacher M; Schabbauer G; Wojta J; Jilma-Stohlawetz P; Jilma B
Thromb Haemost; 2018 Jul; 118(7):1176-1184. PubMed ID: 29864779
[TBL] [Abstract][Full Text] [Related]
16. Colistin dampens fibrinolysis and endothelial activation during endotoxaemia. A randomised, double blind trial.
Schoergenhofer C; Matzneller P; Mußbacher M; Schmid JA; Jilma-Stohlawetz P; Zeitlinger M; Jilma B
Thromb Haemost; 2017 Aug; 117(9):1714-1721. PubMed ID: 28796276
[TBL] [Abstract][Full Text] [Related]
17. Blockade of GPIIb/IIIa by eptifibatide and tirofiban does not alter tissue factor induced thrombin generation in human endotoxemia.
Derhaschnig U; Pachinger C; Schweeger-Exeli I; Marsik C; Jilma B
Thromb Haemost; 2003 Dec; 90(6):1054-60. PubMed ID: 14652636
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia.
Renckens R; Weijer S; de Vos AF; Pater JM; Meijers JC; Hack CE; Levi M; van der Poll T
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):483-8. PubMed ID: 14739127
[TBL] [Abstract][Full Text] [Related]
19. Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans.
van der Poll T; Coyle SM; Levi M; Jansen PM; Dentener M; Barbosa K; Buurman WA; Hack CE; ten Cate JW; Agosti JM; Lowry SF
Blood; 1997 May; 89(10):3727-34. PubMed ID: 9160678
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees.
van der Poll T; Levi M; van Deventer SJ; ten Cate H; Haagmans BL; Biemond BJ; Büller HR; Hack CE; ten Cate JW
Blood; 1994 Jan; 83(2):446-51. PubMed ID: 8286742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
